These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 6750199

  • 1. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
    Halliday WJ, Koppi TA, McKenzie IF.
    J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
    [Abstract] [Full Text] [Related]

  • 2. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 3. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF.
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract] [Full Text] [Related]

  • 4. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
    Biasi G, Saggin L, Dazzi F, De Rossi A, Collavo D.
    J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
    [Abstract] [Full Text] [Related]

  • 5. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E, Klein G.
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract] [Full Text] [Related]

  • 6. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL.
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [Abstract] [Full Text] [Related]

  • 7. Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumors. I. Cell and serum activity detected by leukocyte adherence inhibition.
    Koppi TA, Halliday WJ.
    J Natl Cancer Inst; 1981 Jun; 66(6):1089-96. PubMed ID: 6264193
    [Abstract] [Full Text] [Related]

  • 8. Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumors. II. Nature of blocking and unblocking factors in serum.
    Koppi TA, Halliday WJ, McKenzie IF.
    J Natl Cancer Inst; 1981 Jun; 66(6):1097-102. PubMed ID: 6165853
    [Abstract] [Full Text] [Related]

  • 9. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA, Mentzer SJ, Maizel SE.
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [Abstract] [Full Text] [Related]

  • 10. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.
    Greene MI, Fujimoto S, Sehon AH.
    J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667
    [Abstract] [Full Text] [Related]

  • 11. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K, Petersson M, Ciupitu AM, Wen T, Klein G, Kiessling R.
    Cancer Res; 1995 Dec 01; 55(23):5648-55. PubMed ID: 7585649
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B, Manohar V, Sugimoto T, Ashley MP, Kato Y, Rappaport P.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [Abstract] [Full Text] [Related]

  • 15. Purification and partial characterization of a tumor-specific blocking factor from sera of mice with growing chemically induced sarcomas.
    Nepom JT, Hellström I, Hellström KE.
    J Immunol; 1976 Nov 01; 117(5 Pt.2):1846-52. PubMed ID: 62792
    [Abstract] [Full Text] [Related]

  • 16. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW, Skurzak HM, Andersson B, Whitten HD, Klein E.
    J Immunol; 1975 Apr 01; 114(4):1171-6. PubMed ID: 1117138
    [Abstract] [Full Text] [Related]

  • 17. Augmented immunogenicity of tumor cell membranes produced by infection with influenza virus as compared to Moloney sarcoma virus.
    Takeichi N, Austin FC, Oikawa T, Boone CW.
    Cancer Res; 1978 Dec 01; 38(12):4580-4. PubMed ID: 214226
    [Abstract] [Full Text] [Related]

  • 18. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F, Jongeneel CV.
    J Immunol; 1977 Aug 01; 119(2):623-9. PubMed ID: 196025
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.